Amantadine

ATC Code N04BB01

Amantadine

Definition

A synthetic tricyclic amine with antiviral, antiparkinsonian, and antihyperalgesic activities. Amantadine appears to exert its antiviral effect against the influenza A virus by interfering with the function of the transmembrane domain of the viral M2 protein, thereby preventing the release of infectious viral nucleic acids into host cells. Furthermore, this agent prevents virus assembly during virus replication. Amantadine exerts its antiparkinsonian effects by stimulating the release of dopamine from striatal dopaminergic nerve terminals and inhibiting its pre-synaptic reuptake. This agent may also exert some anticholinergic effect through inhibition of N-methyl-D-aspartic acid (NMDA) receptor-mediated stimulation of acetylcholine, resulting in antihyperalgesia.

Also known as AMANTADINE — per NCIT

Also identified as

Indications

Disease Relation Source
Influenza may prevent MEDRT · Public domain (U.S. Government work)
Drug-induced akathisia may treat MEDRT · Public domain (U.S. Government work)
Drug-induced dyskinesia may treat MEDRT · Public domain (U.S. Government work)
Influenza may treat MEDRT · Public domain (U.S. Government work)
Parkinson's disease may treat MEDRT · Public domain (U.S. Government work)
Secondary Parkinson disease may treat MEDRT · Public domain (U.S. Government work)

Organ Effects

Organ Side effect / interaction Source
Central nervous system may treat a disease of this organ DERIVED · CC BY 4.0
Nervous system may treat a disease of this organ DERIVED · CC BY 4.0

2 entries above are marked DERIVED: Atlas Médico inferred them by combining two sourced claims, and no source asserts these links directly. Treat them as a navigation aid, not as a clinical statement.